Skip to main content
editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
American Journal of Pharmacy and Health Research

American Journal of Pharmacy and Health Research

American Journal of Pharmacy and Health Research

Submit your research to AJPHR — a peer-reviewed, open access pharmacy journal with fast publication and 5–7 day review. Submit now

📢 Latest Update: Call for Papers 2026 | Submit Your Research to an International Peer-Reviewed Open Access Pharmacy Journal

📢 Latest Update: Call for Papers 2026 | Submit Your Research to an International Peer-Reviewed Open Access Pharmacy Journal

Important Journal Details

Title:
American Journal of Pharmacy and Health Research
Journal Short Name:
AJPHR
e-ISSN (Online):
2321-3647
Year of Establishment:
2013
Frequency of the Publication:
Monthly (1 Issue / month)
Publication Format:
Online
Scope:
International
Publication URL:
https://ajphr.com
Related Subject:
Health ResearchPharmacyPharmaceutical ResearchToxicology
Language:
English
Editor-in-Chief:
Dr H J Patel
Editorial Board:
Click Here →

Download Forms & Formats

Download Hub

Journal Features

Rigorous Peer Review

All submissions to our peer reviewed journal in pharmacy and health research undergo expert evaluation to ensure quality and scientific validity.

Global Reach

As an international open access pharmacy journal, AJPHR provides global visibility to researchers, academicians, and industry professionals

Rapid Publication

Our fast publication pharmacy journal ensures timely review and publication without compromising research quality.

Open Access

AJPHR is an open access pharmacy journal for global research visibility, making all published papers freely accessible online.

Publication Procedure

1

Prepare Manuscript

Format your paper according to our guidelines

View Guidelines
style="fill: var(--journal-600);"
2

Submit Paper

Upload your manuscript through our system

Submit Now
3

Peer Review

Your paper undergoes expert evaluation

Learn More
4

Publication

Accepted papers are published worldwide

View Publications
View All Issues
Cover image for Molecular Mechanisms In the Pathogenesis of Diabetic Nephropathy: Historical Development, Intracellular Signalling Pathways, Molecular Targets and Contemporary Therapeutic Strategies

Molecular Mechanisms In the Pathogenesis of Diabetic Nephropathy: Historical Development, Intracellular Signalling Pathways, Molecular Targets and Contemporary Therapeutic Strategies

Devansh Mehta

Diabetic nephropathy (DN), increasingly described within the broader clinical framework of diabetic kidney disease (DKD), represents a major microvascular complication of diabetes mellitus and a leading contributor to chronic kidney disease and end-stage kidney failure worldwide. Its pathogenesis involves complex interactions among chronic hyperglycaemia, haemodynamic abnormalities, oxidative stress, inflammatory mediators, mitochondrial dysfunction, endothelial injury, podocyte damage and progressive extracellular matrix accumulation. Historically, the understanding of DN has evolved from morphological descriptions of glomerulosclerosis to the identification of hyperfiltration, renin–angiotensin–aldosterone system activation and multiple intracellular signalling networks. This review examines the historical development and molecular basis of DN, emphasising advanced glycation end-products and receptor for advanced glycation end-products signalling, protein kinase C activation, polyol and hexosamine pathways, transforming growth factor-β/Smad signalling, nuclear factor-κB, mitogen-activated protein kinases, phosphatidylinositol-3-kinase/Akt/mTOR, AMP-activated protein kinase, Nrf2/Keap1, Wnt/β-catenin and NLRP3 inflammasome activation. Particular attention is given to podocyte dysfunction, glomerular endothelial abnormalities, tubular metabolic stress, epigenetic regulation and renal fibrosis. Contemporary therapeutic strategies, including renin–angiotensin system inhibitors, sodium–glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists, are evaluated alongside landmark clinical trials and emerging molecular interventions. The review also discusses integrated treatment approaches, biomarker-based risk stratification and future therapeutic directions. Understanding the convergence of metabolic, haemodynamic and inflammatory pathways is essential for developing individualised, evidence-based interventions capable of delaying renal disease progression and improving long-term cardiorenal outcomes.

Cover image for Azoxymethane in Experimental Pharmacology: Molecular Mechanisms, Colorectal Carcinogenesis and Therapeutic Research Applications

Azoxymethane in Experimental Pharmacology: Molecular Mechanisms, Colorectal Carcinogenesis and Therapeutic Research Applications

Devansh Mehta

Azoxymethane (AOM) is a synthetic alkylating procarcinogen widely employed in experimental pharmacology, toxicology and molecular oncology for investigating colorectal carcinogenesis. Although it does not possess an established therapeutic indication, its pharmacological and toxicological properties provide an important experimental framework for understanding chemical carcinogenesis and evaluating potential chemopreventive and anticancer interventions. Following metabolic activation, principally through cytochrome P450-dependent pathways, AOM generates methylating intermediates capable of producing DNA adducts, including O⁶-methylguanine. These alterations contribute to mutagenesis, epithelial dysregulation and colorectal tumour initiation. The combination of AOM with dextran sodium sulphate (DSS) has further established a reproducible experimental model of inflammation-associated colorectal cancer. This review examines the historical development, chemical characteristics, pharmacokinetic considerations, metabolic bioactivation, molecular mechanisms, cellular responses and toxicological profile of AOM. Particular attention is given to DNA damage, DNA repair mechanisms, KRAS and Wnt/β-catenin signalling, NF-κB activation, oxidative stress, NLRP3 inflammasome activity, apoptosis, autophagy and interactions with the intestinal microbiome. Contemporary applications in pharmacological research, including chemoprevention, natural-product evaluation, immunotherapy, microbiome-directed interventions and experimental drug screening, are discussed. Recent developments through 2026 highlight the importance of standardising AOM/DSS models and integrating microbiome, metabolomic and lipidomic investigations. The review concludes that AOM remains an important experimental carcinogenesis tool, provided its carcinogenic nature, model limitations and lack of direct therapeutic utility are recognised. Its principal translational value lies in facilitating the discovery and preclinical evaluation of safer and more effective colorectal cancer prevention and treatment strategies.

Cover image for Pomegranate Peel Extract-Loaded Hydrogels for Wound Healing: Bioactive Constituents, Mechanisms, Formulation Strategies and Recent Advances Dr. Satish Kilaje¹, Asmita Bhagate¹, Bushra Dafedar¹, Shubham Patil1

Pomegranate Peel Extract-Loaded Hydrogels for Wound Healing: Bioactive Constituents, Mechanisms, Formulation Strategies and Recent Advances Dr. Satish Kilaje¹, Asmita Bhagate¹, Bushra Dafedar¹, Shubham Patil1

Dr. Satish Kilaje, Asmita Bhagate, Bushra Dafedar, Shubham Patil

Wound healing is a coordinated biological process involving hemostasis, inflammation, proliferation, angiogenesis, re-epithelialization, extracellular-matrix deposition and tissue remodeling. Delayed healing may be associated with oxidative stress, persistent inflammation, microbial infection, impaired angiogenesis and inadequate tissue regeneration. Pomegranate (Punica granatum L.) peel is a rich source of polyphenolic constituents, particularly hydrolyzable tannins and phenolic acids, including punicalagin, punicalin, ellagic acid and gallic acid. These constituents have demonstrated antioxidant, anti-inflammatory and antimicrobial activities in experimental studies. However, direct topical application of plant extracts may be limited by instability, short residence time and uncontrolled release. Hydrogel wound dressings provide hydrated polymeric networks that can maintain a moist wound environment, absorb exudate and support localized delivery of bioactive compounds. Experimental investigations have examined pomegranate peel extract (PPE) in gelatin membranes, hyaluronic-acid/silver-nanoparticle systems, pH-responsive starch-based films, chitosan/PEG/ZnO nanocomposites, carbomer gels and gelatin methacryloyl (GelMA) hydrogels containing pomegranate-peel-derived extracellular vesicles. These studies report encouraging preclinical findings, including improvements in wound closure, epithelialization, granulation tissue formation, collagen deposition and infection-associated outcomes. This review focuses on the phytochemical composition of pomegranate peel, biological mechanisms relevant to wound repair, hydrogel and related polymeric dressing strategies, formulation and characterization considerations, recent technological developments, limitations and future perspectives. The available evidence supports further investigation of PPE-based delivery systems; however, extract standardization, mechanistic validation, long-term safety assessment, manufacturing reproducibility and clinical evaluation remain necessary before clinical translation. Despite this growing body of work, a focused comparison of PPE-loaded hydrogel and related polymeric wound-dressing systems is needed. The reported formulations differ in extract preparation, phytochemical composition, polymer selection, crosslinking strategy, release characteristics and biological evaluation. These differences complicate comparisons of formulation performance and therapeutic outcomes. Accordingly, this review integrates pomegranate peel phytochemistry with hydrogel formulation science and wound-healing biology, with emphasis on formulation strategies, characterization, preclinical evidence, technological advances and barriers to clinical translation. Pomegranate peel contains hydrolyzable tannins, phenolic acids, flavonoids and other secondary metabolites. The relative abundance of these constituents varies with cultivar, geographical origin, fruit maturity, dying

Publication Procedure

Learn about our 4-step publication process

Author Guidelines

Review requirements before submitting

Submit Article

Ready to submit your research?

936
Published Articles
1,523
Active Researchers
195
Countries
4.2
Impact Factor
Whatsapp